Category: | Local government office, |
---|---|
Address: | 4848 Lemmon Ave, Dallas, TX 75219, USA |
Postal code: | 75219 |
Phone: | (214) 363-5374 |
There are no reviews yet!
You can review this Business and help others by leaving a comment. If you want to share your thoughts about pds, use the form below and your opinion, advice or comment will appear in this space.
Davies Imperial Coatings, Inc. PDS-5374. Revision date:2/1/2010. Page #1 of 2. Product Data Sheet Low VOC Acrylic Blue Traffic Marking Paint. #5374. Davies Imperial Coatings, Inc. 1275 State Street Hammond, IN 46320.
STANDARD MOTOR PRODUCTS PDS214 Door Lock Switch.
Артикул. PDS0214. Бренд. PATRON.
Buy Aquarian Drumhead Pack (PDS214): Tom-Tom Accessories - Amazon.com ✓ FREE DELIVERY possible on eligible purchases. B003XU743A. Item model number. PDS214.
Terminals Type: 2 Pin Male Terminals. Whether you're a professional technician or DIYer, you'll appreciate this engine management product from Standard that is second-to-none in quality and fit. Standard PDS214.
Please note that not all documents in the library function with keyword search and not all PDS documents are available through this content library. Pds-pln-project application pds-pln-wireless.
The 214D has been designed utilizing Bryant's Puron refrigerant. The environmentally sound refrigerant allows consumers to make a responsible decision in the protection of the When the 214D is used as a replacement component in a system with a piston fan coil, use the indoor piston size specified below
Sikagrout 214-11 Pds - Free download as PDF File (.pdf), Text File (.txt) or read online for free. Sikagrout 214-11 compensates for shrinkage in both the plastic and hardened states. Complies to Corps of Engineers specification CRD C-621 and ASTM C-1107.
Piedziņas vārpsta Patron PDS0214 tikai par EUR - lieliskas cenas, augsta kvalitāte un ātra piegāde! Pērc PartSale.lv.
PDS0101. NKTR-214 with Opdivo Earns FDA's Breakthrough Therapy Designation for Advanced Melanoma. NKTR-214, or bempegaldesleukin, is Nektar Therapeutics ' lead immuno-oncology candidate.